Autoimmune Hepatitis: A Single-Center Experience on Treatment Response Rates and Their Association with Cirrhosis
Acta Gastro-Enterologica Belgica · 2026
DOI: 10.51821/89.3.15604 ↗At a glance
Journal article in Acta Gastro-Enterologica Belgica, 2026. Written by I Büyüktorun and 6 co-authors. Institution: Department of Gastroenterology, Dokuz Eylul University Hospital, Izmir, 35330 Turkiye. Major MEDLINE topics: Hepatitis, Autoimmune, Liver Cirrhosis, Immunosuppressive Agents.
Abstract (original language)
Objective
This study aimed to evaluate treatment responses in patients with autoimmune hepatitis (AIH) and overlap syndromes and to investigate the association between treatment response and cirrhosis development.
Methods
Between 2010 and 2025, 469 patients diagnosed with AIH at a single center were screened. After exclusion of patients who did not meet international diagnostic criteria, 234 patients were included and categorized as AIH (n = 130) and AIH with overlap syndrome (AIH+OS; comprising AIH+PBC and AIH+PSC) (n = 104). Demographic characteristics, treatment responses, cirrhosis prevalence, and potential predictors of cirrhosis were recorded. Treatment responses were classified according to International Autoimmune Hepatitis Group criteria.
Results
Median ages were 57 (44-67) and 59 (47-67) years in the AIH and AIH+OS groups, respectively, with female predominance in both groups. Cirrhosis prevalence was similar between groups (36.2% vs. 38.5%; p = 0.689). Complete biochemical response rates were 75.4% in AIH and 72.1% in AIH+OS; insufficient response rates were 19.2% and 16.3%, and non-response rates were 5.4% and 8.7% (p = 0.546). Cirrhosis was more frequent in patients with non-response (93.8%) and insufficient response (76.2%) than in those with complete biochemical response (23.1%) (p < 0.001). Advanced fibrosis at diagnosis was the most common contributing factor (57.5%).
Conclusion
Treatment responses are comparable in AIH and overlap syndromes. Achieving a complete biochemical response is crucial to prevent cirrhosis. Patients with insufficient response, non-response, or advanced fibrosis at diagnosis require close monitoring due to poorer prognosis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Gastroenterology, Dokuz Eylul University Hospital, Izmir, 35330 Turkiye.
- Department of Internal Medicine, Dokuz Eylul University Hospital, Izmir, 35330 Turkiye.
Cite
APA
Büyüktorun, I., Gavcar, D., Mehtiyev, R., Binicier, H., Dolu, S., Danis, N., & Akarsu, M. (2026). Autoimmune Hepatitis: A Single-Center Experience on Treatment Response Rates and Their Association with Cirrhosis. Acta Gastro-Enterologica Belgica. https://doi.org/10.51821/89.3.15604
Vancouver
Büyüktorun I, Gavcar D, Mehtiyev R, Binicier H, Dolu S, Danis N, et al. Autoimmune Hepatitis: A Single-Center Experience on Treatment Response Rates and Their Association with Cirrhosis. Acta Gastro-Enterologica Belgica. 2026. doi:10.51821/89.3.15604
BibTeX
@article{Byktorun2026,
author = {Büyüktorun, I and Gavcar, D and Mehtiyev, R and Binicier, H and Dolu, S and Danis, N and Akarsu, M},
title = {Autoimmune Hepatitis: A Single-Center Experience on Treatment Response Rates and Their Association with Cirrhosis},
journal = {Acta Gastro-Enterologica Belgica},
year = {2026},
doi = {10.51821/89.3.15604}
}
EUVIMED